Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2008 Feb 19;105(8):2975–2980. doi: 10.1073/pnas.0800053105

HSP90/70 chaperones are required for rapid nucleosome removal upon induction of the GAL genes of yeast

Monique Floer 1, Gene O Bryant 1, Mark Ptashne 1,*
PMCID: PMC2268570  PMID: 18287040

Abstract

Induction of transcription of the GAL genes of yeast by galactose is a multistep process: Galactose frees the activator Gal4 of its inhibitor, Gal80, allowing Gal4 to recruit proteins required to transcribe the GAL genes. Here, we show that deletion of components of either the HSP90 or the HSP70 chaperone machinery delays this induction. This delay remains when the galactose-signaling pathway is bypassed, and it cannot be explained by a chaperone requirement for DNA binding by Gal4. Removal of promoter-bound nucleosomes is delayed in a chaperone mutant, and our findings suggest an involvement of HSP90 and HSP70 in this early step in gene induction.

Keywords: transcription, Gal4, activation, recruitment, promoter


HSP90, HSP70, and their cochaperones (often referred to as chaperone machineries) are required for an array of processes during normal cell growth, in addition to their roles in preventing protein aggregation during heat shock and cell stress (15). In a few cases, it has been possible to pinpoint a specific step in a pathway at which the chaperones work. For example, the binding of hormones to receptors that activate gene transcription in mammalian cells (e.g., glucocortoid receptor and estrogen receptor) depends on HSP90 (6). It also has been suggested that HSP90 and various cochaperones play a role in transcriptional activation subsequent to hormone binding by promoting the cycling of receptor complexes on and off DNA (7, 8). In yeast, binding of heme to the transcriptional activator, Hap1 (a step required for activation by Hap1), is facilitated by HSP90 (9), and it has been proposed that HSP90 also may be involved in a step subsequent to heme binding (10). HSP90 is believed to work, in some cases at least, in conjunction with members of the HSP70 class of chaperones (6, 11), and a HSP90/HSP70 complex has been described (12).

The GAL genes of yeast (e.g., GAL1) are induced by addition of galactose to cells growing in culture. Galactose signaling frees DNA-bound Gal4 from the inhibitor Gal80, which results in recruitment by Gal4 of the various proteins required to transcribe the gene. Here, we show that rapid induction of the GAL genes requires components of both the HSP90 and HSP70 chaperone machineries, and we attempt to ascertain the earliest event in gene activation that is facilitated by these chaperones. We induce Gal4-mediated transcription in two ways that do not require transmission of the galactose signal to Gal80 and find that, nevertheless, induction is delayed in strains lacking one or more chaperone machinery components. DNA binding by Gal4 is not affected by loss of the chaperones, but the time course of recruitment of the transcriptional machinery to the GAL1 promoter by Gal4 (previously determined in ref. 13) is delayed. We then turn to a recently developed nucleosome-positioning assay (G.O.B., V. Prabhu, M.F., D. Spagna, D. Schreiber, and M.P., unpublished data), that has allowed us to determine the dynamics of nucleosome binding at the GAL1 promoter and of their removal upon induction. For the work presented here, the important finding of that unpublished study is that, upon induction in a wild-type strain, nucleosomes are quickly removed from the GAL1 promoter. Here, we find that promoter nucleosome removal is delayed in a chaperone mutant, and we suggest that chaperones are involved in this early step of gene activation.

Results

The HSP90 and HSP70 Chaperone Machineries Are Required for Rapid GAL1 Induction.

Fig. 1A shows that induction of transcription of GAL1 (by the addition of galactose to cells growing in raffinose) was delayed by the deletion of hsc82, a member of the HSP90 family. Full induction, which was reached within 20–30 min in wild-type cells, was reached only after ≈2 h in the mutant cells. We observed (Fig. 1B) a more dramatic delay in induction of GAL1 with a strain deleted for hsc82 and expressing a point-mutant form of hsp82 (14), the other member of the HSP90 family. We also assayed induction in a strain expressing a temperature-sensitive mutant of hsp82 (14). As shown in Fig. 1C, we found that GAL1 mRNA production was delayed when the temperature was increased before induction. Sti1 has been reported to be a cochaperone for HSP90 and HSP70 separately (15, 16) and also to link HSP90 and HSP70 in a complex (12, 17, 18). Fig. 1D shows that deletion of sti1 also affected GAL1 induction. Moreover, as shown in Fig. 1 E and F, induction was delayed when members of the HSP70 chaperone machinery were deleted. These members include Ssa1 and Ssa2 (Fig. 1E) and (the strongest effect) Ydj1 (Fig. 1F). Control genes (including ACT1) were expressed at wild-type levels in these various mutant strains, indicating that the mutations did not lead to a general impairment of transcription.

Fig. 1.

Fig. 1.

Gene expression is delayed in yeast cells deleted or mutant for components of the HSP90 and HSP70 chaperone machineries. Cells growing in raffinose were induced with galactose as described in Materials and Methods. GAL1 mRNA is depicted as fold over ACT1 mRNA, which remained constant over the course of an induction. Filled symbols show measurements for wild-type cells, and open symbols show cells deleted for hsc82 (A), deleted for hsc82 and hsp82 and expressing a mutant version of hsp82 (T101I) (B), deleted for both hsc82 and hsp82 and expressing the temperature-sensitive mutant hsp82 (G170D) (C), deleted for sti1 (D), deleted for both ssa1 and ssa2 (two members of the SSA class of HSP70 chaperones) (29) (E), and deleted for ydj1 (F), which acts as an HSP40 for the SSA proteins (30, 31). Cells were grown at 30°C except for the experiment shown in C, in which cells were shifted to 36°C for 1 h before galactose addition. mRNA was isolated and reverse transcribed as described in Materials and Methods. The resulting cDNA in the experiments described in this and the following figures was measured in quadruplicates, with a standard deviation <20%.

Recruitment of the Transcriptional Machinery by Gal4 Is Delayed in the hsc82 Mutant.

Fig. 2 shows the effect of the deletion of hsc82 on the recruitment of the transcriptional machinery as measured by ChIP analysis. Fig. 2 A–D shows that the transcriptional machinery (including SAGA, mediator, TFIIE, and Pol II) was recruited more slowly to the GAL1 promoter when these cells were induced by galactose. We examined the levels of two of these proteins (Spt20, a component of SAGA; and Rpb1, the large subunit of Pol II) and found that they were not affected by the deletion of hsc82 (data not shown). As shown in Fig. 2 E and F, we found that the Hsc82 and Ssa1 proteins were recruited to the GAL1 promoter (a 4- and 2-fold increase, respectively) upon induction. A more pronounced effect (a 6- and 3-fold increase, respectively) was seen in the coding region of GAL1.

Fig. 2.

Fig. 2.

Recruitment of the transcriptional machinery is delayed in cells deleted for hsc82, and Hsc82 and Ssa1 are directly recruited to GAL1 in wild-type cells. (A–D) Cells that were either wild type (filled symbols) or deleted for hsc82 (open symbols) were induced with galactose, and ChIP experiments were performed as described in Materials and Methods. Values are depicted as the ratio of immunoprecipitated DNA at the GAL1 promoter over that precipitated at the promoter of ACT1. ChIP experiments were performed with antibodies against the HA-epitope in cells in which the endogenous SPT20 gene (a component of the SAGA complex) was fused to the HA-epitope (A), Gal11 (a mediator component) (B), Tfa2 (a subunit of TFIIE) (C), and Pol II (D). (E and F) ChIP experiments were performed with antibodies against Hsc82 (E) and Ssa1 (F), with cells grown in raffinose (open bars) or cells that had been induced by galactose addition for 80 min (filled bars). The average of two samples each taken before and after induction is shown. Chaperone binding was measured at the GAL1 promoter or in the GAL1 ORF, values were normalized to the promoter of ACT1, and the fold increase in binding is depicted. Binding at the GAL1 promoter before induction was arbitrarily set to 1.

Delayed GAL1 Induction Is Not Due to Defects in Galactose Signaling or DNA Binding by Gal4.

In attempting to explain the delay in induction and the recruitment of the transcriptional machinery, we considered and eliminated two possibilities: Chaperones might affect the transmission of the galactose signal to Gal80 or Gal4 binding to DNA. Fig. 3 A and B shows two examples of Gal4-mediated transcription that do not require galactose signaling. Yet in both cases, transcription was delayed in a chaperone mutant. In the experiment of Fig. 3A, Gal4-mediated transcription in a gal80-deleted strain was repressed by extended growth in glucose, an effect that was then relieved by transferring the cells to medium lacking glucose. The figure shows that this form of induction was significantly delayed in cells deleted for hsc82 compared with wild type. Fig. 3B describes an experiment in which the fusion protein TetR-Gal4 activated a reporter gene, and here again in the chaperone mutant, in this case the cells were deleted for ydj1, induction was delayed.

Fig. 3.

Fig. 3.

The effect of chaperones on GAL1 expression is downstream of galactose signaling and Gal4 DNA binding. (A) Yeast cells that were deleted for gal80 and gal4 contained a shortened Gal4 activator and were either wild type (filled symbols) or deleted for hsc82 (open symbols) and were grown in SC media containing 2% glucose. GAL1 expression was induced by shifting the cells to media containing 2% galactose and 2% raffinose. GAL1 mRNA is depicted as fold over ACT1. (B) A schematic of the tetracycline-inducible reporter is shown above the figure. Cells bearing the Tet-reporter and also expressing a fusion of TetR to an activation domain of Gal4 were either wild type (filled squares) or deleted for ydj1 (open squares). Cells were grown in SC media containing 2% glucose and 2 μg/ml DOX, and reporter gene expression was induced by removal of the antibiotic. Reporter HIS3 mRNA is depicted as fold over ACT1. (C) ChIP experiments with an antibody against the DNA-binding domain of Gal4 were performed as described in Materials and Methods for cells grown in raffinose with or without galactose. Immunoprecipitated DNA was measured at the UASg, and values are depicted as the ratio of immunoprecipitated DNA at the promoter of ACT1. Squares are as in A.

The experiment of Fig. 3C shows that Gal4 bound to DNA efficiently in the absence of a chaperone. Thus, deletion of hsc82 did not affect the levels of Gal4 bound to the UASg (upstream activating sequence galactose), as measured by a ChIP experiment, in cells grown in either raffinose or in raffinose plus galactose. Similar results were seen in cells deleted for the other chaperones of Fig. 1 (data not shown). We did not detect cycling of Gal4 on and off DNA in wild-type cells when Gal4 DNA binding was analyzed at 30-s intervals after the addition of galactose (G.O.B. and M.P., unpublished data), a result supported by previously reported findings (19). We examined the turnover of total Gal4 protein in yeast cells and found that it was not significantly affected by the deletion of hsc82 or ssa1 and ssa2 (data not shown).

Promoter Nucleosome Removal Is Greatly Delayed in Cells Deleted for hsc82.

The data presented thus far showed that the delay in GAL1 gene induction and in the recruitment of the transcriptional machinery seen in strains deleted for components of the HSP90 and HSP70 chaperone machineries was not due to a defect in galactose signaling or in DNA binding by Gal4. An early process mediated by Gal4 upon induction of GAL1 is the removal of promoter nucleosomes (G.O.B., V. Prabhu, M.F., D. Spagna, D. Schreiber, and M.P., unpublished data). To determine whether this process requires HSP90, we turned to the method developed in that study. Briefly, the method determines the sensitivity of specific DNA regions to micrococcal nuclease over a wide range of enzyme concentrations. This analysis allows us to determine the fraction of a given DNA segment in a population of cells that is protected by a nucleosome, and thus to follow the course of nucleosome removal upon induction. Fig. 4 shows that the removal of promoter nucleosomes at GAL1, upon induction, was greatly impaired in cells deleted for hsc82. The figure describes the removal of the single nucleosome positioned just to the right of the UASg, and the other two nucleosomes shown in the figure behaved essentially identically. Thus, whereas in wild-type cells nucleosome removal was complete by 12 min in the chaperone mutant nucleosome occupancy decreased by only ≈20% within the first hour of induction.

Fig. 4.

Fig. 4.

Nucleosomes at the GAL1 promoter are removed more slowly in the absence of hsc82. Nucleosome occupancy was measured by the method of G.O.B., V. Prabhu, M.F., D. Spagna, D. Schreiber, and M.P. (unpublished data). The nucleosomes are indicated in green in the schematic above the figure, and the location measured is indicated by the black bar. Gal4-binding sites are indicated in light blue, and TATAA elements are indicated in dark blue. The transcriptional and translational start sites of the flanking GAL1 and GAL10 genes are indicated in gray and black, respectively. Cells were either wild type (filled squares) or deleted for hsc82 (open squares) and were induced by the addition of galactose.

Discussion

Our findings suggest that removal of promoter nucleosomes at the GAL genes by DNA-bound Gal4 is facilitated by the HSP90/HSP70 chaperone machineries. Our findings that components of both HSP70 and HSP90 complexes, as well as the protein Sti1 [which can link the two chaperone complexes (12, 17, 18)], are all required for efficient nucleosome removal, and that both machineries are recruited to the GAL1 promoter upon induction, suggest that these proteins work together in this early step of gene induction. Of the various complexes that affect nucleosome binding in vitro (e.g., SWI/SNF, RSC, and INO80), none has been shown to be required for induction of the GAL genes in vivo. In contrast, it is reported that SWI/SNF, working with the so-called histone chaperone Asfl, is required for efficient induction of the PHO5 gene (21, 22). There are reports of synthetic lethality generated by deletion of part of the HSP90/70 complexes and a so-called histone chaperone (Hir1) (23), on the one hand, and HSP90 and the INO80 and SWI/SNF remodelling complexes on the other (20). It remains to be seen what general rules, if any, might emerge governing nucleosome removal effected by protein complexes recruited by transcriptional activators.

Materials and Methods

Saccharomyces cerevisiae Strains.

We used strains derived from BY4741 (MATα, his3Δ1, leu2Δ0, met15Δ0, and ura3Δ0 S288C) deleted for hsc82, sti1, or ydj1 obtained from the European Saccharomyces Cerevisiae Archive for Functional Analysis. We also disrupted the GAL4 and GAL80 genes in BY4741 and the hsc82 deletion derivative by inserting a PCR fragment containing the HIS5 gene from Schizosaccharomyces pombe in the coding region of GAL4 and the LEU2 gene at GAL80. Details on the primers used to create the respective PCR fragments can be provided on request. The strains thus created expressed a fusion of the minimal activation domain of Gal4 to its DNA-binding domain from a plasmid (see below). We also used an hsc82 deletion strain derived from W303α (can1–100, ade2–1, his3–11,15, trp1–1, and ura3–1) provided by Susan Lindquist (Whitehead Institute for Biomedical Research, Cambridge, MA). Results obtained with this strain and the BY4741 derivative were indistinguishable. Point mutants hsp82 T101I and G170D have been described previously (14). A strain deleted for hsc82 requires the expression of wild-type Hsp82 or one of these mutants for viability. The strain deleted for ssa1 and ssa2 was a derivative of strain W303α (leu2–3,112, trp1–1, ura3–1, his3–11,15, lys2Δ, can1–100, and ade2–1) and was provided by Elizabeth A. Craig (University of Wisconsin, Madison, WI). The strains used to detect SAGA recruitment were derivatives of BY4741 bearing a fusion of the endogenous SPT20 gene to the HA-epitope tag.

We also used derivatives of the strain NLY2 (MATα, ura3–52, his3Δ200, leu2–1, lys-, trp1Δ63, gal4−, and gal80−) (24), which had a Tet-reporter integrated at the URA3 locus. Derivatives of this strain that were deleted for ydj1 were created by inserting a PCR fragment containing the TRP1 gene into the coding region of YDJ1, which resulted in complete removal of the YDJ1 ORF. The resulting strains expressed a fusion of an activation domain of Gal4 to the Tet repressor (TetR) from a plasmid (see below).

Plasmids.

The plasmid bearing a fusion of an activation domain of Gal4 to its DNA-binding domain was constructed by inserting a PCR fragment containing the GAL4 promoter and the DNA-binding domain of GAL4 (442 bp upstream of the ATG to 441 bp downstream) into vector pRS316 as an EcoRI/HindIII fragment. Then a PCR fragment containing the minimal activation domain of Gal4 (amino acids 840–881) and the GAL4 terminator (200 bp) was inserted into the resulting vector as a HindIII/KpnI fragment. Primers used to create the corresponding PCR fragments can be given on request. The tetracycline inducible reporter was constructed by modification of the reporter described previously (25). In brief, the cassette containing the TetOR sites, the CYC1 promoter, and the lacZ gene were excised from vector pCM145 and inserted into pYIplac211 as an EcoRI/HindIII fragment. Subsequently, the lacZ gene was replaced with the HIS3 gene from S. cerevisiae. The TetR-GAL4 activation domain fusion was constructed by inserting a PCR fragment containing the activation domain of Gal4 (amino acids 768–881) into vector pCM240 as an NcoI/SalI fragment. Primers used to create the PCR fragment can be given on request.

Antibodies.

We used antibodies against Gal4 (sc-577; Santa Cruz Biotechnology), HA-1 (sc-7392; Santa Cruz Biotechnology), and RNA polymerase II (8WG16; Covance). Antibodies against Gal11 and Tfa2 were synthesized in the laboratory and have been described previously (26). The antibody against Hsc82 was provided by Susan Lindquist and was generated against a C-terminal peptide of Hsc82. The antibody against Ssa1 was synthesized for this study against recombinantly expressed protein purified from Escherichia coli.

Purification of Recombinant Ssa1 for Antibody Generation.

The SSA1 gene from S. cerevisiae was amplified with primers 5′-TATGCTCGAGATGTCAAAAGCTGTC-3′ and 5′-AGACGGATCCTTAATCAACTTCTTC3-′ from genomic DNA. The resulting XhoI/BamHI fragment was inserted into vector pET15b (Novagen), creating an N-terminal 6xHIS-fusion protein. The protein was expressed in E. coli strain BL21-CodonPlus(DE3)-RIL (Stratagene). In brief, the cells were grown in LB media containing ampicillin to an OD600 of 0.6 at 37°C. Cells were induced with 0.5 mM isopropyl β-d-1-thiogalactopyranoside and grown for 20 h at 17°C. Cells were then harvested and resuspended in buffer A [30 mM K2HPO4/KH2PO4, 100 mM KCl, 6 mM imidazol, and protease inhibitor mixture (complete minus EDTA; Roche) (pH 8.5)]. Cells were lyzed in a French pressure cell, and the cell lysate was treated with DNAseI (Roche) in the presence of 5 mM MgOAc2. Ssa1 protein was purified from the soluble fraction on a HIS-Trap column (GE Healthcare/Life Sciences) with a gradient from 6–600 mM imidazol. The fractions containing Ssa1 were pooled, and the purified protein was injected into rabbits for antibody production according to standard procedures (Cocalico Biologicals).

Cell Growth.

Yeast cells were grown exponentially overnight at 30°C to an OD600 of 0.2–0.5 before induction. For galactose induction, cells were grown in SC media containing 2% raffinose, and then 2% galactose was added. For other experiments, cells were grown in media containing 2% glucose, followed by resuspension in media containing 2% raffinose and 2% galactose. For tetracycline induction, cells were grown in media containing 2% glucose and 2 μg/ml doxycycline (DOX). Cells were washed once with media lacking DOX, followed by resuspension of the cells in the same media.

mRNA Measurements.

mRNA was extracted from cells by a modified version of the hot acid phenol extraction method (27). On average, mRNA of 10 ml of yeast cell culture was extracted. After extraction, the mRNA was reverse transcribed by AMV reverse transcriptase (Roche) according to the manufacturer's instructions, and the resulting cDNA was measured by quantitative real-time PCR with primers corresponding to fragments in the GAL1, HIS3, or ACT1 loci as indicated in the figure legends. The final levels of GAL1 mRNA showed some variability from experiment to experiment presumably due to differences in cell growth and in the individual reverse transcriptase reactions. For this reason, each individual experiment was performed with a mutant strain and its corresponding wild type side by side.

ChIP Experiments.

ChIP experiments with antibodies against the HA-epitope, Gal4, Gal11, Tfa2, and PolII were performed as described previously (13). For the ChIP experiments with antibodies against Hsc82 and Ssa1, we used a modified version of the protocol described previously (28), the details of which can be given on request.

cDNA and DNA Measurements by Real-Time Quantitative PCR.

cDNA and DNA was measured by real-time quantitative PCR on a 7900HT (ABI) or a Light Cycler 480/384 (Roche) as described previously (ref. 13 and G.O.B., V. Prabhu, M.F., D. Spagna, D. Schreiber, and M.P., unpublished data). For cDNA measurements, primers used were 5′-TGCTCGATCCTTCTTTTCCA-3′ and 5′-TTGCGAACACCCTTGTTGTA-3′ for detection of a fragment in the GAL1 coding region 840 bp from the ATG; 5′-AACTGGGACGATATGGAAAA-3′ and 5′-GAAGGCTGGAACGTTGAAAG-3′ for a fragment in the ACT1 coding region 622 bp downstream of the ATG; and 5′-TACGCAGTTGTCGAACTTGG-3′ and 5′-GCGAGGTGGCTTCTCTTATG-3′ for a fragment in the HIS3 coding region 418 bp downstream of the ATG. DNA measurements of ChIP experiments were performed with primers 5′-TGTTCGGAGCAGTGCGGCGC-3′ and 5′-ACGCTTAACTGCTCATTGCT-3′ for detection of a fragment in the UASg (408 bp upstream of the ATG); 5′-TTATGAAGAGGAAAAATTGGCAGTA-3′ and 5′-TGGTTGTTAATTTGATTCGTTAATTTG-3′ in the GAL1/10 promoter (266 bp upstream of the ATG); 5′-TTGAAACCAAACTCGCCTCT-3′ and 5′-ATTGGGAAGGAAAGGATCAAAC-3′ in the ACT1 promoter (254 bp upstream of the ATG); and 5′-AATCATAAATTTAGTCTGTGCTAGTC-3′ and 5′-AAATGAATCGATACAACCTTGGCA-3′ in the PHO5 promoter (251 bp upstream of the ATG).

Micrococcal Nuclease-Sensitivity Experiments.

Micrococcal nuclease-sensitivity experiments were performed by using the method of G.O.B., V. Prabhu, M.F., D. Spagna, D. Schreiber, and M.P. (unpublished data). Briefly, cells were harvested and cross-linked with formaldehyde, and the cross-linked DNA was digested with micrococcal nuclease over a wide range of enzyme concentrations. The amount of DNA remaining after digestion was determined by quantitative PCR and plotted against the concentration of micrococcal nuclease. The data were fitted to a two-state decay curve, with a fast rate for the fraction of DNA that was very sensitive to digestion and a slower rate for the fraction that was highly protected against digestion. This analysis revealed the positioning of nucleosomes flanking the UASg. To determine promoter nucleosome removal upon induction of GAL1 in the absence of HSC82, protection was measured 266 bp upstream of the GAL1 translational start codon with primers 5′-TTATGAAGAGGAAAAATTGGCAGTA-3′ and 5′-TGGTTGTTAATTTGATTCGTTAATTTG-3′.

ACKNOWLEDGMENTS.

We thank Erik Martinez-Hackert, Brian Freeman, Susan Lindquist, and members of the M.P's laboratory for discussions; Susan Lindquist, Elizabeth A. Craig, and Enrique Herrero (Universitat Autonoma de Barcelona, Barcelona, Spain) for yeast strains, plasmids, and antibodies; and Xiaoyang Wu for modifying the tetracycline inducible system described by Herrero et al. (25). This work was supported by a Leukemia and Lymphoma Society of America grant (to M.F.) and a National Institutes of Health grant (to M.P.).

Footnotes

The authors declare no conflict of interest.

References

  • 1.Voellmy R, Boellmann F. Chaperone regulation of the heat shock protein response. Adv Exp Med Biol. 2007;594:89–99. doi: 10.1007/978-0-387-39975-1_9. [DOI] [PubMed] [Google Scholar]
  • 2.Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nature Rev. 2005;5:761–772. doi: 10.1038/nrc1716. [DOI] [PubMed] [Google Scholar]
  • 3.Caplan AJ, Mandal AK, Theodoraki MA. Molecular chaperones and protein kinase quality control. Trends Cell Biol. 2007;17:87–92. doi: 10.1016/j.tcb.2006.12.002. [DOI] [PubMed] [Google Scholar]
  • 4.McClellan AJ, et al. Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell. 2007;131:121–135. doi: 10.1016/j.cell.2007.07.036. [DOI] [PubMed] [Google Scholar]
  • 5.Morano KA. New tricks for an old dog: The evolving world of Hsp70. Ann NY Acad Sci. 2007;1113:1–14. doi: 10.1196/annals.1391.018. [DOI] [PubMed] [Google Scholar]
  • 6.Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003;228:111–133. doi: 10.1177/153537020322800201. [DOI] [PubMed] [Google Scholar]
  • 7.Freeman BC, Yamamoto KR. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science. 2002;296:2232–2235. doi: 10.1126/science.1073051. [DOI] [PubMed] [Google Scholar]
  • 8.Stavreva DA, Muller WG, Hager GL, Smith CL, McNally JG. Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol Cell Biol. 2004;24:2682–2697. doi: 10.1128/MCB.24.7.2682-2697.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lee HC, Hon T, Zhang L. The molecular chaperone Hsp90 mediates heme activation of the yeast transcriptional activator HapI. J Biol Chem. 2002;277:7430–7437. doi: 10.1074/jbc.M106951200. [DOI] [PubMed] [Google Scholar]
  • 10.Lan C, Lee HC, Tang S, Zhang L. A novel mode of chaperone action: Heme activation of HapI by enhanced association of Hsp90 with the repressed Hsp70-HapI complex. J Biol Chem. 2004;279:27607–27612. doi: 10.1074/jbc.M402777200. [DOI] [PubMed] [Google Scholar]
  • 11.Wegele H, Wandinger SK, Schmid AB, Reinstein J, Buchner J. Substrate transfer from the chaperone Hsp70 to Hsp90. J Mol Biol. 2006;356:802–811. doi: 10.1016/j.jmb.2005.12.008. [DOI] [PubMed] [Google Scholar]
  • 12.Chang HC, Lindquist S. Conservation of Hsp90 macromolecular complexes in Saccharomyces cerevisiae. J Biol Chem. 1994;269:24983–24988. [PubMed] [Google Scholar]
  • 13.Bryant GO, Ptashne M. Independent recruitment in vivo by Gal4 of two comlexes required for transcription. Mol Cell. 2003;11:1301–1309. doi: 10.1016/s1097-2765(03)00144-8. [DOI] [PubMed] [Google Scholar]
  • 14.Nathan DF, Lindquist S. Mutational analysis of Hsp90 function: Interactions with a steroid receptor and a protein kinase. Mol Cell Biol. 1995;15:3917–3925. doi: 10.1128/mcb.15.7.3917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chang HC, Nathan DF, Lindquist S. In vivo analysis of the Hsp90 cochaperone Sti1 (p60). Mol Cell Biol. 1997;17:318–325. doi: 10.1128/mcb.17.1.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wegele H, Haslbeck M, Reinstein J, Buchner J. Sti1 is a novel activator of the Ssa proteins. J Biol Chem. 2003;278:25970–25976. doi: 10.1074/jbc.M301548200. [DOI] [PubMed] [Google Scholar]
  • 17.Chen S, Smith DF. Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery. J Biol Chem. 1998;273:35194–35200. doi: 10.1074/jbc.273.52.35194. [DOI] [PubMed] [Google Scholar]
  • 18.Flom G, Behal RH, Rosen L, Cole DG, Johnson JL. Definition of the minimal fragments of Sti1 required for dimerization, interaction with Hsp70 and Hsp90 and in vivo functions. Biochem J. 2007;404:159–167. doi: 10.1042/BJ20070084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nalley K, Johnston SA, Kodadek T. Proteolytic turnover of the Gal4 transcription factor is not required for function in vivo. Nature. 2006;442:1054–1057. doi: 10.1038/nature05067. [DOI] [PubMed] [Google Scholar]
  • 20.Zhao R, et al. Navigating the chaperone network: An integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell. 2005;120:715–727. doi: 10.1016/j.cell.2004.12.024. [DOI] [PubMed] [Google Scholar]
  • 21.Adkins MW, Howar SR, Tyler JK. Chromatin disassembly mediated by the histone chaperone Asf1 is essential for transcriptional activation of the yeast PHO5 and PHO8 genes. Mol Cell. 2004;14:657–666. doi: 10.1016/j.molcel.2004.05.016. [DOI] [PubMed] [Google Scholar]
  • 22.Korber P, et al. The histone chaperone Asf1 increases the rate of histone eviction at the yeast PHO5 and PHO8 promoters. J Biol Chem. 2006;281:5539–5545. doi: 10.1074/jbc.M513340200. [DOI] [PubMed] [Google Scholar]
  • 23.Caplan AJ, Ma'ayan A, Willis IM. Multiple kinases and system robustness: A link between Cdc37 and genome integrity. Cell Cycle. 2007;6:3145–3147. doi: 10.4161/cc.6.24.5147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Saha S, Brickman JM, Lehming N, Ptashne M. New eukaryotic transcriptional repressors. Nature. 1993;363:648–652. doi: 10.1038/363648a0. [DOI] [PubMed] [Google Scholar]
  • 25.Gari E, Piedrafita L, Aldea M, Herrero E. A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression in Saccharomyces cerevisiae. Yeast. 1997;13:837–848. doi: 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  • 26.Barberis A, et al. Contact with a component of the polymerase II holoenzyme suffices for gene activation. Cell. 1995;81:359–368. doi: 10.1016/0092-8674(95)90389-5. [DOI] [PubMed] [Google Scholar]
  • 27.Kirby KS. Isolation of nucleic acids with phenolic solvents. Methods Enzymol. 1968;12B:87. [Google Scholar]
  • 28.Metivier R, et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell. 2003;115:751–763. doi: 10.1016/s0092-8674(03)00934-6. [DOI] [PubMed] [Google Scholar]
  • 29.Werner-Washburne M, Stone DE, Craig EA. Complex interactions among members of an essential subfamily of hsp70 genes in Saccharomyces cerevisiae. Mol Cell Biol. 1987;7:2568–2577. doi: 10.1128/mcb.7.7.2568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Caplan AJ, Douglas MG. Characterization of YDJ1: A yeast homologue of the bacterial dnaJ protein. J Cell Biol. 1991;114:609–621. doi: 10.1083/jcb.114.4.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Becker J, Walter W, Yan W, Craig EA. Functional interaction of cytosolic hsp70 and a DnaJ-related protein, Ydj1p, in protein translocation in vivo. Mol Cell Biol. 1996;16:4378–4386. doi: 10.1128/mcb.16.8.4378. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES